Duke Early Phase Clinical Research
Duke Early Phase Clinical Research combines clinical and operational expertise to accelerate the availability of therapies, diagnostics, and medical devices to humans. As part of the Duke Clinical Research Institute—the world’s largest academic research organization—the Early Phase team partners with pharmaceutical, biotech, medical device, government agencies, foundations, and academic centers to conduct a broad range of early phase studies. From our state-of-the-art 34-bed research unit to robust analytics, we offer our partners a new path to proof by building on our strength of expertise and experience, including:
- Thought leadership and scientific insight in early phase clinical research
- Duke practicing physicians who see patients every day
- Full-service capabilities and customized study design grounded in the reality of clinical care
- Access to healthy and diverse disease-specific patient populations
Join Us For An Open House - May 3
Duke Early Phase Clinical Research cordially invites you to join us for an open house celebration.
Our faculty and staff will host two tours (noon – 2:00 p.m. and 3:00 – 5:00 p.m.) of our Early Phase unit.
We will also hold a panel discussion highlighting our ability to bring validation to innovation for a new path to proof.
Areas of Therapeutic Expertise
The DCRU has experience across therapeutic areas and pulls from the broad expertise of Duke's translational faculty.